搜索优化
English
全部
Copilot
图片
视频
地图
资讯
购物
更多
航班
旅游
酒店
搜索
笔记本
Top stories
Sports
U.S.
Local
World
Science
Technology
Entertainment
Business
More
Politics
时间不限
过去 1 小时
过去 24 小时
过去 7 天
过去 30 天
按相关度排序
按时间排序
3 天
Canaccord下调Voyager Therapeutics目标价至$12,维持买入评级
周四,Canaccord Genuity维持对Voyager Therapeutics(NASDAQ:VYGR)的买入评级,但将其股票目标价从$14.00下调至$12.00。此次调整是基于公司2024年第四季度业绩以及最近关于其肌萎缩性侧索硬化症(ALS)基因疗法项目VY9323的公告。根据 InvestingPro ...
当前正在显示可能无法访问的结果。
隐藏无法访问的结果
今日热点
North Macedonia deadly fire
Pleads not guilty
Israeli attack in Gaza
Chiefs sign Tillery
Texas measles outbreak
Coffee creamer recall
Wins longest-ever Iditarod
US launches strikes in Yemen
Severe weather outbreak
RU, UKR launch attacks
Syed formally resentenced
Kupp signs with Seahawks
Villanova fires head coach
Gold rises to new heights
Trump signs funding bill
Electrical fire halts show
SK: Massive rallies erupt
Cuba suffers power outage
Felony gun possession arrest
US expels SA ambassador
Second protester arrested
Deportation order blocked
Staff placed on leave
Kellogg's envoy role reduced
Laceration hazard recall
ISIS leader killed in Iraq
Influencer leaves Australia
Child abuse images sentence
Man wins $50M over burns
To review F-35 jets purchase
反馈